top of page
BioRN Espresso_web2.png

GRAB YOUR COFFEE... AND DIAL-IN!

The BioRN Espresso is the meeting place to meet, discuss and cooperate with peers.
It is a structured way to exchange on general operational topics of high relevance for SMEs.

The concept is to share hands-on experiences and solutions to common challenges

Do you want to lead one of the discussions?

Contact us and share your idea!

14 March @ 9 - 10.30 am

Battle for talents? Boost your recruiting success

with ‘Perfect match’ and ‘positive psychology’ strategies.

with  Thomas Winter, Founder and Managing Director, Genius Search GmbH & Co. KG 

Hiring talents for small biotech companies and startups has become very challenging in the past years. The well-known lack of resources for recruiting and HR in small companies, has been exacerbating by the shortage of candidates with the skills needed and the constant competition with global pharmaceutical and biotech companies, that also in uncertain times can provide stability.
In order to improve the chances of hiring the best talent possible, small companies must play to their strengths. In this BioRN espresso Thomas Winter (Genius Search) will provide tips for a bold HR strategy that meets the current recruiting trends in biotech.

Past BioRN Espresso:

April 2020 –  ‘Reacting to Covid-19 pandemic’: How emerging biotechs and small biopharmaceutical companies are dealing with it? Moderated by Volker Stadler, CEO - PEPperPRINT GmbH & BioRN Executive Board

​Impulse Talks from:

  • ​Claus Kremoser, CEO - Phenex Pharmaceuticals AG & BioRN Executive Board

  • Christoph Schröder, CEO - Sciomics GmbH

  • Oliver Bosnjak, CEO - Biomex GmbH

  • Andreas Kempff, Managing Director - Chamber of Industry and Commerce (IHK) Rhine-Neckar

Read Press Release

June 2020 –  ‘Business Development and Partnering: opportunities and challenges during pandemic times.’ Moderated by Jürgen Gamer, VP Business Development Apogenix AG & BioRN Strategic Board

Impulse Talks from:

  • Thomas Hegendoerfer, New Ventures Lead in Germany for J&J Innovation & BioRN Strategic Board

  • Frank Hensel, Investment Manager, High-Tech Gründerfonds

  • Rainer Wessel, Director Innovation Management, German Cancer Research Center (DKFZ) & BioRN Strategic Board

Read Press Release

September 2020 –  ‘Having difficulties getting access to your market?' Moderated by Susanne Kuhlendahl (marcommotion) Communication & Marketing Expert

Impulse Talks from:

  • Veronique Schwarz (faCellitate), Venture Team Leader

  • George Badescu (Heidelberg Pharma), Business Development

  • Fior Casilag (PEPperPRINT), Business Development

June 2021 –  ‘Digitalisation as innovation motor for small and medium-sized enterprises?' 

Impulse Talks from:

  • Katja Betts (PROGEN), Managing Director

  • Lisa Held (HWI pharma services GmbH), Expert Pharmacovigilance

  • Annette Deichmann (GeneWerk), Managing Director

September 2021 –  Home office, Office or both? The future of work is hybrid!'

Impulse Talks from:

  • Annette Sättele, Partner, Labour and Employment Law Specialist - RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB

  • Katarina Bohm - Sales Manager Pharma Biotech - Promega GmbH

  • Susanne Huber - Human Resources Manager - Promega GmbH

February 2022 –  Access to patient data and samples: Different perspectives and main issues'

Impulse Talks from:

  • Peter Schirmacher - Director of the Institute of Pathology - Heidelberg University Hospital

  • Andreas Schmidt - CEO - Proteona

  • Philipp Mann - Senior Partnership Manager - Owkin

May 2022 - What is in it for me? Why engage in industry collaborations centered on clinical data.

Impulse Talks from:

  • Oyunaa von Stackelberg, Head of Research and Policy at Diagnostic and Interventional Radiology - University Hospital Heidelberg

  • Matthias P. A. Ebert, Director  II. Medizinische Klinik - University Clinic Mannheim 

December 2022 - Is GDPR really the obstacle for data exchange as commonly claimed?

Impulse Talks from:

  • Barbara Tomasi, Data Protection Officer, MyData-Trust

  • Melanie Börries, Institut für Med. Bioinformatik und Systemmedizin, University Hospital Freiburg

bottom of page